Click on the tab to search across Lilly for additional information

The Healthcare Professional's connection to Lilly product and condition information

Search across Lilly Select a search category, select a topic from the pull-down menu, add optional keyword(s), then click on the search button

Product:

Condition:

Byetta^®
(exenatide) injection Capastat^® Sulfate
(capreomycin for injection, USP) Cialis^®
(tadalafil) Cymbalta^®
(duloxetine hydrochloride) Evista^®
(raloxifene HCl) Forteo^®
(teriparatide [rDNA origin] injection) Lilly Glucagon
(glucagon by injection [rDNA origin]) Humalog^®
(insulin lispro injection [rDNA origin]) Humalog^® Mix50/50™
(50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin]) Humalog^® Mix75/25™
(75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin]) Humulin^®
(human insulin [rDNA origin]) Humatrope^®
(somatropin [rDNA origin] for injection) Prozac^®
(fluoxetine hydrochloride) Quinidine Gluconate Injection, USP
ReoPro^®
(abciximab) Seromycin^®
(cycloserine capsules, USP) Symbyax^®
(olanzapine and fluoxetine hydrochloride) Xigris^®
(drotrecogin alfa [activated]) Zyprexa^®
(olanzapine)

Acute Bipolar Mania Adult Growth Hormone Deficiency Bipolar Depression Diabetes Diabetic Peripheral Neuropathic Pain (DPNP) Erectile Dysfunction Idiopathic Short Stature (ISS) Major Depressive Disorder (MDD) Osteoporosis Pediatric Growth Hormone Deficiency Schizophrenia Severe Sepsis Turner Syndrome

Click on the tab to search across Lilly for additional information

Cymbalta® (duloxetine HCl) is approved for the treatment of depression and generalized anxiety disorder, and for the management of diabetic peripheral neuropathic pain and fibromyalgia.

Product Information

Cymbalta and GAD

Patients with generalized anxiety disorder (GAD) have excessive anxiety and worry, occuring more days than not for at least 6 months, about a number of events or activities. Patients with GAD often find it difficult to control their excessive anxiety or worry, and these symptoms are accompanied by at least 3 of the following: restlessness, becoming easily fatigued, difficulty concentrating, irritability, muscle tension, and disturbed sleep. These symptoms cause clinically significant distress or impairment with work, social, or other important areas of functioning.¹

Cymbalta Demonstrated Improvement in Patients With GAD

Demonstrated Improvement: In clinical trials of GAD, Cymbalta significantly reduced anxious symptoms and improved functioning in patients with GAD^2-7
Safety and tolerability: Learn about treatment-emergent adverse events associated with Cymbalta and GAD
Simplicity: Cymbalta offers simple once-daily dosing⁸

References:

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC; American Psychiatric Association; 2000.
Data on file, Lilly Research Laboratories: CYM20090505F.
Koponen H, et al. (Prim Care Companion) J Clin Psychiatry. 2007;9(2):100-107.
Rynn M, et al. Depress Anxiety. 2008;25(3):182-189.
Hartford J, et al. Int Clin Psychopharmacol. 2007;22(3):167-174.
Endicott J, et al. J Clin Psychiatry. 2007;68(4):518-524.
Nicolini H, et al. Psychol Med. 2009;39(2):267-276.
Cymbalta full Prescribing Information, 2009.

Formulary Access Finder

Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.

Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.

Register to Receive Information From Cymbalta

Keep up-to-date on the latest developments with Cymbalta. Sign up now for our periodic emails.